Shaping the landscape of interstitial lung disease in idiopathic inflammatory myopathies: state of the art, evidence gaps and a need for clinical trials

Key Points

To assess the current understanding and highlight evidence gaps in the relationship between interstitial lung disease and idiopathic inflammatory myopathies.
Conducted a comprehensive literature review.
Evaluated existing studies and clinical data.
Identified areas lacking robust evidence for effective treatment.
Documented the prevalence of interstitial lung disease in idiopathic inflammatory myopathies.
Highlighted significant gaps in clinical trial data.
Emphasized the necessity for upcoming clinical trials to address treatment options.

Answers are grounded in this paper and cite their sources.

Review highlights evidence gaps in interstitial lung disease among idiopathic inflammatory myopathies, suggesting a need for clinical trials.

No abstract yet. The journal hasn't published one we can show.

No takes yet. Share an insight, caveat, or question.

Gallegos et al. (2026) studied this question.

View at Publisher

Ask AI

Bookmark

Share